Silo Pharma (SILO) Free Cash Flow (2010 - 2026)

Silo Pharma has reported Free Cash Flow for 14 years, with the latest figure at -$822623.0 in Q1 2026.

• Quarterly Free Cash Flow rose 49.85% year-over-year to -$822623.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (up 17.09% YoY) and the FY2025 annual result came in at -$4.7 million, down 21.58% from the prior year.
• Free Cash Flow slipped to -$822623.0 in Q1 2026 per SILO's latest filing, from -$780278.0 in the prior quarter.
• Over five years, Free Cash Flow peaked at -$400109.0 in Q2 2022 and troughed at -$1.6 million in Q1 2025.
• A 5-year average of -$943529.2 and a median of -$885989.0 in 2022 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2026: Free Cash Flow plunged 147.14% in 2022, then jumped 49.85% in 2026.
• Over 5 years, Free Cash Flow stood at -$885989.0 in 2022, then fell by 2.71% to -$910012.0 in 2023, then retreated by 0.82% to -$917432.0 in 2024, then increased by 14.95% to -$780278.0 in 2025, then slipped by 5.43% to -$822623.0 in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$822623.0, -$780278.0, and -$955493.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.